Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

15 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Olaparib as Treatment Versus Nonplatinum Chemotherapy in Patients With Platinum-Sensitive Relapsed Ovarian Cancer: Phase III SOLO3 Study Final Overall Survival Results.
Scambia G, Villalobos Valencia R, Colombo N, Cibula D, Leath CA 3rd, Bidziński M, Kim JW, Nam JH, Madry R, Hernández C, Mora PAR, Ryu SY, Ah-See ML, Lowe ES, Lukashchuk N, Carter D, Penson RT. Scambia G, et al. Among authors: villalobos valencia r. J Clin Oncol. 2024 Dec 12:JCO2400933. doi: 10.1200/JCO.24.00933. Online ahead of print. J Clin Oncol. 2024. PMID: 39668137
First-Line Lenvatinib Plus Pembrolizumab Versus Chemotherapy for Advanced Endometrial Cancer: A Randomized, Open-Label, Phase III Trial.
Marth C, Moore RG, Bidziński M, Pignata S, Ayhan A, Rubio MJ, Beiner M, Hall M, Vulsteke C, Braicu EI, Sonoda K, Wu X, Frentzas S, Mattar A, Lheureux S, Chen X, Hasegawa K, Magallanes-Maciel M, Choi CH, Shalkova M, Kaen D, Wang PH, Berger R, Okpara CE, McKenzie J, Yao L, Orlowski R, Khemka V, Gilbert L, Makker V; ENGOT-en9/LEAP-001 Investigators. Marth C, et al. J Clin Oncol. 2024 Nov 26:JCO2401326. doi: 10.1200/JCO-24-01326. Online ahead of print. J Clin Oncol. 2024. PMID: 39591551
Ramucirumab with cisplatin and fluoropyrimidine as first-line therapy in patients with metastatic gastric or junctional adenocarcinoma (RAINFALL): a double-blind, randomised, placebo-controlled, phase 3 trial.
Fuchs CS, Shitara K, Di Bartolomeo M, Lonardi S, Al-Batran SE, Van Cutsem E, Ilson DH, Alsina M, Chau I, Lacy J, Ducreux M, Mendez GA, Alavez AM, Takahari D, Mansoor W, Enzinger PC, Gorbounova V, Wainberg ZA, Hegewisch-Becker S, Ferry D, Lin J, Carlesi R, Das M, Shah MA; RAINFALL Study Group. Fuchs CS, et al. Lancet Oncol. 2019 Mar;20(3):420-435. doi: 10.1016/S1470-2045(18)30791-5. Epub 2019 Feb 1. Lancet Oncol. 2019. PMID: 30718072 Clinical Trial.
IMpassion132 double-blind randomised phase III trial of chemotherapy with or without atezolizumab for early relapsing unresectable locally advanced or metastatic triple-negative breast cancer.
Dent R, André F, Gonçalves A, Martin M, Schmid P, Schütz F, Kümmel S, Swain SM, Bilici A, Loirat D, Villalobos Valencia R, Im SA, Park YH, De Laurentis M, Colleoni M, Guarneri V, Bianchini G, Li H, Kirchmayer Machackova Z, Mouta J, Deurloo R, Gan X, Fan M, Mani A, Swat A, Cortés J. Dent R, et al. Among authors: villalobos valencia r. Ann Oncol. 2024 Jul;35(7):630-642. doi: 10.1016/j.annonc.2024.04.001. Epub 2024 May 15. Ann Oncol. 2024. PMID: 38755096 Free article. Clinical Trial.
The Effects of Nebivolol-Gefitinib-Loratadine Against Lung Cancer Cell Lines.
Martínez-Lira JL, Hernández-Gallegos E, DE Guadalupe Chávez-López M, Villalobos-Valencia R, Camacho J. Martínez-Lira JL, et al. Among authors: villalobos valencia r. In Vivo. 2024 Nov-Dec;38(6):2688-2695. doi: 10.21873/invivo.13746. In Vivo. 2024. PMID: 39477390 Free PMC article.
Advanced, recurrent, and persistent cervical cancer management: in the era of immunotherapy.
Galicia-Carmona T, Arango-Bravo EA, Coronel-Martínez JA, Cetina-Pérez L, Vanoye-Carlo EG, Villalobos-Valencia R, García-Pacheco JA, Cortés-Esteban P. Galicia-Carmona T, et al. Among authors: villalobos valencia r. Front Oncol. 2024 Aug 5;14:1392639. doi: 10.3389/fonc.2024.1392639. eCollection 2024. Front Oncol. 2024. PMID: 39161386 Free PMC article. Review.
Addressing the unmet needs of women with breast cancer in Mexico: a non-randomised pilot study of the digital ePRO intervention.
Contreras Sánchez SE, Doubova SV, Martinez Vega IP, Grajales Álvarez R, Villalobos Valencia R, Dip Borunda AK, Lio Mondragón L, Martínez Pineda WJ, Nuñez Cerrillo JG, Huerta López AD, Zalapa Velázquez R, Mendoza Ortiz V, Vázquez Zamora VJ, Montiel Jarquín ÁJ, García Galicia A, Talamantes Gómez EI, Sánchez Reyes R, Aguirre Gómez J, Ayala Anzures ME, Zapata Tarrés M, Monroy A, Leslie HH. Contreras Sánchez SE, et al. Among authors: villalobos valencia r. BMJ Open. 2024 Jun 21;14(6):e087240. doi: 10.1136/bmjopen-2024-087240. BMJ Open. 2024. PMID: 38908841 Free PMC article.
Navigating HER2-Low Testing in Invasive Breast Cancer: Update Recommendations for Pathologists.
Bornstein-Quevedo L, de Anda-González J, Lara-Torres CO, Flores-Gutiérrez JP, Dorantes-Heredia R, Bautista-Piña V, Zaragoza-Vargas P, Alcaraz-Wong A, Soto-Sañudo AK, Mendoza-Ramírez S, Salamanca-García M, Loyola-Rodríguez G, Gómez-Macías GS, Murguia-Perez M, De Luna-Sánchez M, Villalobos-Valencia R, Talamantes E, Arce-Salinas C. Bornstein-Quevedo L, et al. Among authors: villalobos valencia r. J Pers Med. 2024 Apr 28;14(5):467. doi: 10.3390/jpm14050467. J Pers Med. 2024. PMID: 38793049 Free PMC article. Review.
Darolutamide and Survival in Metastatic, Hormone-Sensitive Prostate Cancer.
Smith MR, Hussain M, Saad F, Fizazi K, Sternberg CN, Crawford ED, Kopyltsov E, Park CH, Alekseev B, Montesa-Pino Á, Ye D, Parnis F, Cruz F, Tammela TLJ, Suzuki H, Utriainen T, Fu C, Uemura M, Méndez-Vidal MJ, Maughan BL, Joensuu H, Thiele S, Li R, Kuss I, Tombal B; ARASENS Trial Investigators. Smith MR, et al. N Engl J Med. 2022 Mar 24;386(12):1132-1142. doi: 10.1056/NEJMoa2119115. Epub 2022 Feb 17. N Engl J Med. 2022. PMID: 35179323 Free PMC article. Clinical Trial.
15 results